TY  - GEN 
AU  - Macías, Juan
AU  - Mancebo, María
AU  - Merino, Dolores
AU  - Téllez Pérez, Francisco de Paula
AU  - Montes Ramírez, M. Luisa
AU  - Pulido, Federico
AU  - Rivero Juárez, Antonio
AU  - Raffo, Miguel
AU  - Pérez Pérez, Montserrat
AU  - Merchante, Nicolás
AU  - Cotarelo, Manuel
AU  - Pineda, Juan A.
A4  - Medicina
PY  - 2017
SN  - 1537-6591
SN  - 1058-4838
UR  - http://hdl.handle.net/10498/36672
AB  - Background. Antiretroviral drugs with a lower potential to induce hepatic steatosis in human immunodeficiency virus (HIV) infection need to be identified. We compared the effect of switching efavirenz (EFV) to raltegravir (RAL) on hepatic steatosis...
LA  - eng
PB  - Oxford University Press
KW  - HIV
KW  - nonalcoholic fatty liver disease
KW  - efavirenz
KW  - raltegravir
TI  - Changes in liver steatosis after switching from efavirenz to raltegravir among human immunodeficiency virus-infected patients with nonalcoholic fatty liver disease
DO  - 10.1093/CID/CIX467
ER  -